Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Industry Trends
  • Published:

The carbohydrate-based drug industry

Nature Biotechnology volume 15, pages 479–480 (1997)Cite this article

Whether used as a target or a tool carbohydrates face manufacturing challenges before they can realize their true value.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dwek, R.A. 1996. Glycobiology: Toward understanding the function of sugars. Chem. Rev. 96: 683–720.

    Article  CAS  Google Scholar 

  2. Frechet, J.M. and Schuerch, C. 1971. Solid-phase tri-saccharide synthesis. J. Am. Chem. Soc. 93: 492–496.

    Article  Google Scholar 

  3. Bednarski, M. and Simon, E.S. (eds.). 1991. Enzymes in Carbohydrate Synthesis, ACS Series 446. American Chemical Society, Washington, DC.

    Google Scholar 

  4. Borman, S. 1994. Chemical-enzymatic technique used to make carbohydrates, glycopeptides. Chem. Eng. News 72 37–39.

    Google Scholar 

  5. Borman, S. Review & Company Database: Carbohydrate Therapeutics—1997. Edition. ASSETT, e-mail: assettnetor.gr.

  6. Boons, G-T. 1996. Synthetic oligosaccharides: Recent advances. Drug Dev. Today. 1: 331–342.

    Article  CAS  Google Scholar 

  7. Persidis, A. 1995. Enabling technologies and the business of science. Bio/Technology 13: 1172–1176.

    CAS  Google Scholar 

  8. These companies are Alpha-Beta Technology, Biomira, Cytel, Glycomed, Ligand Pharmaceuticals, Martek, Neose Technologies, and Oxford GlycoSciences.

  9. Persidis, A. 1997. Industry trends: Combinatorial chemistry. Nature Biotechnology 15: 391–393.

    Article  CAS  Google Scholar 

  10. Rouhi, M. 1996. Carbohydrates combinatorially. Chem. Eng. News 74: 4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. vice president for business development, Argonex Inc., 2044 India Road, Charlottesville, VA, 22901

    Aris Persidis

Authors
  1. Aris Persidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persidis, A. The carbohydrate-based drug industry. Nat Biotechnol 15, 479–480 (1997). https://doi.org/10.1038/nbt0597-479

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0597-479

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing